Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
February 20th, 2021
2.5K views
Reported here is a protocol for the quantification of infectious viral particles using real-time monitoring of electrical impedance of infected cells. A practical application of this method is presented by quantifying influenza A virus decay under different physicochemical parameters mimicking environmental conditions.
Overview
This article presents a protocol for quantifying infectious viral particles through real-time monitoring of electrical impedance in infected cells. The method is exemplified by assessing the decay of the influenza A virus under various environmental conditions.
Key Study Components
Area of Science
- Virology
- Cell Biology
- Infectious Diseases
Background
- Particle quantification is essential in biological research.
- Traditional methods for measuring viral data can be labor-intensive.
- Real-time data collection enhances precision and efficiency.
- This method is applicable to all viruses that cause cytopathic effects.
Purpose of Study
- To provide a reliable protocol for viral particle quantification.
- To demonstrate the advantages of real-time monitoring over traditional methods.
- To explore the impact of environmental factors on viral decay.
Methods Used
- Real-time monitoring of electrical impedance.
- Quantification of viral particles in infected cells.
- Assessment of influenza A virus decay.
- Evaluation under varying physicochemical parameters.
Main Results
- The protocol allows for precise real-time quantification.
- It reduces reliance on labor-intensive endpoint assessments.
- Demonstrated effectiveness across different viral types.
- Provides insights into the effects of environmental conditions on viral stability.
Conclusions
- The method enhances the accuracy of viral quantification.
- It offers a practical approach for studying viral behavior in various conditions.
- This protocol can be widely applied in virology research.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is the ability to quantify viral particles in real-time, improving precision and reducing labor.
Can this method be used for all viruses?
Yes, it is applicable to all viruses that induce a cytopathic effect.
Who demonstrates the procedure?
Quentin Grassin, a laboratory technician, demonstrates the procedure.
What environmental factors are considered in the study?
The study examines various physicochemical parameters that mimic environmental conditions.
How does this method compare to traditional techniques?
This method provides objective real-time data, avoiding the limitations of traditional, labor-intensive techniques.
Executive Industry Relevance
Real-time impedance-based viral quantification enables rapid, sensitive assessment of viral stability under environmental stress, supporting antiviral development and formulation stability studies. By replacing labor-intensive endpoint assays, this method accelerates screening of inactivation kinetics across virus strains and conditions. It provides mechanistic insights into viral persistence, informing target selection for broad-spectrum antivirals and de-risking preclinical candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of viral environmental stability to clarify inactivation mechanisms and identify resilience factors.
- Operational Value: Supports high-throughput comparison of viral decay slopes under controlled physicochemical conditions.
- Predictive Value: Generates quantitative inactivation kinetics to prioritize targets with favorable environmental susceptibility profiles.
Screening & Assay Development
- Scientific Value: Delivers label-free, real-time readouts of cytopathic effect progression with high sensitivity to small titer changes.
- Operational Value: Standardizes viral quantification across experiments through automated impedance monitoring, reducing variability.
- Assay Readiness: Produces continuous, quantitative data suitable for screening antiviral compounds or environmental modifiers.
Translational & Preclinical Research
- Translational Continuity: Bridges in vitro stability data with ex vivo environmental exposure models to predict viral transmission potential.
- Mechanistic De-risking: Links hemagglutinin structural variants to environmental survival, informing antigen design for broader protection.
- Preclinical Modeling: Supports dose-response modeling of inactivation agents (e.g., sanitizers, pH modifiers) under physiologically relevant conditions.
Pipeline & Workflow Integration
This method fits within the antiviral discovery continuum from early target validation through lead optimization, enabling data-driven decisions on viral susceptibility and formulation robustness.
- Discovery Biology: Facilitates hypothesis testing on viral environmental resilience by quantifying real-time inactivation kinetics.
- Assay Development: Delivers reproducible, quantitative viral titer measurements without fixation or staining, enabling longitudinal monitoring.
- Analytics: Provides CIT50 values and inactivation slopes as quantitative endpoints for comparing viral stability across conditions.
- Translational Research: Connects lab-based stability data to real-world transmission risk by modeling environmental decay profiles.
- Enterprise Reuse: Establishes a reusable platform for assessing viral stability across influenza strains and other cytopathic viruses.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in viral behavior by reducing mechanistic ambiguity in inactivation pathways.
- Operational Value: Enhances reproducibility and scalability of viral quantification through automated, label-free impedance tracking.
- Strategic Value: Improves go/no-go decisions in antiviral programs by providing early stability profiling under relevant stress conditions.
- Portfolio Impact: Enables risk-adjusted advancement of candidates based on environmental susceptibility and transmission potential.
Implementation Considerations
- Requires expertise in cell culture, virology, and impedance-based instrumentation setup and calibration.
- Dependent on access to real-time cell analysis systems with gold microelectrode biosensors and compatible software.
- Necessitates standardization of cell seeding density, infection timing, and environmental condition controls across runs.
- Adaptation to non-adherent or non-cytopathic viruses may require alternative readouts or cell lines.
- Limited to viruses inducing measurable cytopathic effects; not applicable to non-lytic or persistent infection models without modification.
Biopharma FAQs
Why does real-time impedance measurement matter for viral titer quantification?
It enables label-free, continuous monitoring of cytopathic effect progression, providing quantitative viral titer data with higher sensitivity and reduced labor compared to endpoint assays like plaque formation.
How does isolating the virus as the independent variable support antiviral screening?
By holding cell conditions constant and varying only viral exposure, the method ensures that changes in impedance reflect virus-specific effects, enabling reliable comparison of inactivation kinetics across strains or treatments.
What quantitative measurements does the CIT50 value enable in viral stability studies?
The CIT50 provides a quantitative metric for the time required to reduce viral infectivity by 50%, allowing calculation of inactivation slopes and direct comparison of environmental resistance between virus variants.
Why are replication requirements critical for comparing viral decay across laboratories?
Replication ensures that observed differences in inactivation slopes are due to viral or environmental factors rather than technical variability, supporting cross-functional comparability in antiviral development programs.
What statistical analysis is needed before implementing impedance-based viral quantification in screening workflows?
Baseline impedance stability must be confirmed (between -0.1 and 0.1), and data must be normalized to cell-only controls to distinguish virus-induced effects from background drift, ensuring accurate kinetic modeling.
Chapters in this video
0:04
Introduction
0:41
Influenza A Virus Stock Preparation
2:38
Cell Infection Quantity Determination
4:59
CIT50 Value and Multiplicity of Infection (MOI) Correlation
6:01
Influenza A Virus (IAV) Kinetics
7:10
Results: Representative Influenza Virus External Host Survival Monitoring
8:20
Conclusion
